Food and beverages
From drinks to better-for-you snacks, UHT milk, plant-based products, and even fresh pasta, BPL1® Postbiotic can be easily incorporated into a wide range of foods and beverages.
Support metabolic health with BPL1®
Support metabolic wellness with a versatile postbiotic shown in emerging clinical evidence to help support visceral fat reduction and a healthy waist circumference in combination with a balanced diet and regular exercise¹.
Stable, flexible, and supports metabolic health
BPL1® Postbiotic is a whole-cell, heat-treated, non-living version of our proprietary strain, Bifidobacterium animalis subsp. lactis CECT 8145.
- May help support abdominal visceral fat reduction and a healthy waist circumference, in combination with diet and exercise¹
- Highly stable dried powder that can be added to a range of foods, beverages, and dietary supplements
- In a randomized, double-blind, placebo-controlled clinical study, BPL1® Postbiotic significantly reduced abdominal visceral fat and supported a reduction in waist circumference compared with baseline¹
- Winner of the NutraIngredients Awards 2021, BIG Innovation Awards 2021, and iSEE Technology 2021–2022
A growing focus on healthy weight
As consumers increasingly prioritize healthy weight, maintaining a healthy weight remains a leading global health concern, with growing interest in ways to support long-term wellbeing.
BPL1® Postbiotic metabolic benefits
In a 12-week randomized, double-blind, placebo controlled clinical trial, results showed:
Visceral fat reduction
After 12-weeks, subjects in the BPL1® Postbiotic intervention group showed significant reductions in abdominal visceral fat compared to baseline1.
Healthy waist circumference
The intake of the BPL1® Postbiotic by the subjects in this intervention group led to a significant decrease in waist circumference compared to placebo.
Metabolic health support
Beyond these clinical findings, preclinical evidence suggests BPL1® Postbiotic may help support metabolic health pathways.
ADM’s formulation expertise
ADM is built on innovation, with an advanced level of expertise in conducting proprietary microbiome research. We can help you use BPL1® Postbiotic in existing products that consumers already love, or formulate new offerings.
Dietary supplements
With its preclinically supported metabolic wellness potential, BPL1® Postbiotic is ideal for use in dietary supplement formulations from capsules to tablets, powders, and gummies.
Specialized nutrition
Whether used in specialized or sports nutrition, BPL1® can help add metabolic health benefits to specialist products.
Bonjour! BRB
CODE D’ERREUR : 503
Clinical evidence—BPL1® Postbiotic
Clinical study for metabolic health
A randomized, double-blind, placebo-controlled study1 to understand the role of BPL1® Postbiotic in metabolic health, with exciting results for visceral fat reduction and waist circumference.
Develop with BPL1® Postbiotic
Explore how BPL1® can enhance your product development, with ADM’s end-to-end application support, formulation expertise, and diverse ingredient portfolio.
Bonjour! BRB
CODE D’ERREUR : 503
Voici quelques conseils pratiques
Lorem Ipsum
BPL1® Postbiotic technical details and availability
Explore the technical specifications of BPL1® Postbiotic, including its preparation and composition, concentrations, recommended daily intake, processing stability, and compliance certifications.
Preparation and composition
Concentration and intake
Processing and stability
Compliance and certifications
Bonjour! BRB
CODE D’ERREUR : 503
BPL1® Postbiotic resources
BPL1® Postbiotic product sheet
How BPL1® Postbiotic can support metabolic wellness, including recent clinical evidence.
Pedret et al. (2019) clinical study
The results of the first human clinical trial on BPL1® Postbiotic.
Explore more ADM Postbiotics
Esflorin1 Postbiotic for digestive health
L. gasseri CP2305 for Stress, Mood, and Sleep Support
Postbiotic solutions from ADM
This content is intended for business-to-business (B2B) informational purposes only and not directed to consumers. The information provided summarizes scientific research and should not be interpreted as evidence that any ingredient, product, claim, or statement has been approved, authorized, validated, or accepted by any regulatory authority in any jurisdiction. References to scientific studies do not establish that any claim is permitted for use in a particular jurisdiction or product category. The ingredients described in this content are not intended to diagnose, treat, cure, or prevent any disease. Ingredients, permitted uses, and claims must be reviewed under applicable local laws and regulations before use in any specific product, category, or market by companies for their finished products.
BPL1® is a trademark registered for Biopolis S.L. in the EU and other countries.
Sources
1Pedret et al. (2019), International Journal of Obesity, 43:1863–1868
2World Health Organization (2026), Obesity and overweight, October 2026
3ADM OutsideVoice℠ Global Lifestyle Survey, ADM, 2025